For a starting price of 1,491, Noom Med combines its digital behavioural program with access to GLP-1 medications - assuming youre clinically approved
This could further point towards an increasing error in handling the benefits system, something which has previously been noticed by the Swedish pharmaceutical benefits agency TLV, resulting in a clarification regarding the subsidization limitations in 2023 [48]
Wang F, Wang S, Zong QQ, Zhang Q, Ng CH, Ungvari GS, et al
This presents significant opportunities for telehealth businesses as well, including those: Using GLP-1 recommendations as a strategy to connect subscriber-members with clinicians (as recently done by Weight Watchers), Incorporating GLP-1 companion foods or into (personalized) nutrition and health digitalized businesses, Natural GLP-1 inducers Combining GLP-1 with wearable devices to enhance personalization and improve disease prevention and management
Ethics declarations Conflict of interest The authors declare no competing interests
Liang, Z., Wu, D., Zhang, H